( en | de | ru )

 

Disambiguation of "Guyatt, Gordon"

Author of the publication

copydeleteadd this publication to your clipboard
How to ascertain drug safety in the context of benefit. Controversies and concerns.

, , , , , , , , , , , , , , , , , , , and . The Journal of rheumatology, 36 (9): 2114-21 (September 2009)5429<m:linebreak></m:linebreak>JID: 7501984; 0 (Antirheumatic Agents); ppublish;.
DOI: 10.3899/jrheum.090591

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Artur Gordon

Karina Gordon

Gordon Krenz

Gordon Weinberg

Gordon Whittaker

 

Other publications of authors with the same name

When and how to update systematic reviews: consensus and checklist, , , , , , , , , and 16 other author(s). BMJ, (2016)The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study., , , , , , , , and . PloS one, 6 (10): e25491 (January 2011)6400<m:linebreak></m:linebreak>JID: 101285081; 2011/02/24 received; 2011/09/06 accepted; 2011/10/18 epublish; ppublish;.How to ascertain drug safety in the context of benefit. Controversies and concerns., , , , , , , , , and 10 other author(s). The Journal of rheumatology, 36 (9): 2114-21 (September 2009)5429<m:linebreak></m:linebreak>JID: 7501984; 0 (Antirheumatic Agents); ppublish;.Discrimination and Calibration of Clinical Prediction Models: Users' Guides to the Medical Literature., , , , , , , and . JAMA, 318 (14): 1377-1384 (October 2017)Models predictius; Critical appraisal; Introductori.Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials, , , , , , , , , and 18 other author(s). 403 (10434): e21--e31 (2024)CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement., , , , , , , , , and 3 other author(s). BMJ (Clinical research ed.), 350 (may14 17): h1738 (May 2015)Publicació; Checklist; RCT; N-of-1; Online.Criteria for use of composite end points for competing risks-a systematic survey of the literature with recommendations., , and . Journal of clinical epidemiology, (February 2017)Comparacions múltiples; Composite endpoints; Competing risks.Calculation of absolute risk for important outcomes in patients with and without a prognostic factor of interest., , , and . Journal of clinical epidemiology, (October 2019)Anàlisi de dades; Risc relatiu vs absolut.Treatment effects on patient-important outcomes can be small, even with large effects on surrogate markers., , , and . Journal of clinical epidemiology, 65 (9): 940-5 (September 2012)6788<m:linebreak></m:linebreak>CI: Copyright (c) 2012; JID: 8801383; 2011/08/25 received; 2012/02/15 revised; 2012/02/19 accepted; 2012/05/18 aheadofprint; ppublish;<m:linebreak></m:linebreak>Tamaño del efecto; Surrogate endpoints.How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature., , , , , , , , , and 4 other author(s). JAMA : the journal of the American Medical Association, 312 (2): 171-9 (July 2014)Critical appraisal; Metaanàlisi.